Search results
Results from the WOW.Com Content Network
Robert Ray Courtney (born September 15, 1952) is an American former pharmacist from Kansas City, Missouri. [1] In 2002, after initially being caught diluting several doses of chemotherapy drugs, he pleaded guilty to intentionally diluting 98,000 prescriptions involving multiple types of drugs, which were given to 4,200 patients, and was sentenced to 30 years in federal prison.
In the first off-label promotion case ever litigated in a whistleblower suit under the False Claims Act, the settlement was announced after eight years of litigation in May 2004. Warner-Lambert agreed to pay $430 million to resolve all civil and criminal liability, with $24.64 million going to Franklin for his participation in the lawsuit. [ 2 ]
The following is a list of the 20 largest settlements reached between the United States Department of Justice and pharmaceutical companies from 2001 to 2013, ordered by the size of the total settlement. The settlement amount includes both the civil (False Claims Act) settlement and criminal fine.
This morning, at a courthouse in Fort Worth, Tex., Slync founder Christopher Kirchner is going on trial to face charges of fraud and money laundering.
For premium support please call: 800-290-4726 more ways to reach us
The pharmacy billed for medications that people didn’t receive and overcharged for diabetes test strips. Former Kentucky pharmacy owner admits Medicare fraud, to repay more than $700,000 Skip to ...
But the Arkansas case wasn’t the J&J lawyers’ top concern that day. They were more worried, according to one company lawyer, about a brief that Boston federal prosecutors had just filed with a judge contesting the company’s refusal to make Alex Gorsky available for a deposition in its civil suit over the Risperdal/Omnicare nursing home case.
Pharmaceutical fraud is when pharmaceutical companies engage in illegal, fraudulent activities to the detriment of patients and/or insurers. Examples include counterfeit drugs that do not contain the active ingredient, false claims in packaging and marketing, suppression of negative information regarding the efficacy or safety of the drug, and violating pricing regulations.